This content is machine translated Annual Meeting of the Brain Stroke Society Cerebral amyloid angiopathy – a not so rare cause of cerebral hemorrhage At this year’s annual meeting of the Brain Stroke Society in Aarau, Prof. David Werring, UCL, Institute of Neurology, London (UK), provided information on cerebral amyloid angiopathy (CAA). This disease…
View Post 9 min This content is machine translated Stroke Symposium at the Inselspital Bern Still many unknowns in the management of cerebral hemorrhage On August 21, 2014, a stroke symposium was held at the Inselspital in Bern, organized by the University Department of Neurology. The first presentations focused on the structure and certification of…
View Post 3 min This content is machine translated ARUBA study Drug therapy continues to perform better A new extrapolation on the ARUBA trial shows that the benefit of simple drug therapy over intervention in patients with asymptomatic arteriovenous malformations may last much longer than originally thought.
View Post 7 min This content is machine translated Neuroradiological diagnostics Time is brain – but time isn’t everything The gold standard for acute stroke evaluation is native CT to exclude hemorrhage, after which iv thrombolytic therapy can be administered in the 4.5-hour time window currently allowed and after…
View Post 6 min This content is machine translated Stroke prevention in VHF Real-life data with dabigatran convincing For the first time, real-life data are available for one of the new oral anticoagulants. These were presented in Zurich on October 2, 2013. They demonstrate a compelling safety and…
